First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-13
DOI
10.1038/s41598-021-81025-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex (MAC) pulmonary disease
- (2020) Hadeel Khadawardi et al. EUROPEAN RESPIRATORY JOURNAL
- The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease (MAC-PD): A population-based cohort study
- (2020) Sarah K. Brode et al. EUROPEAN RESPIRATORY JOURNAL
- Long-Term Treatment Outcome of Progressive Mycobacterium avium Complex Pulmonary Disease
- (2020) Kiyoharu Fukushima et al. Journal of Clinical Medicine
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis
- (2020) Hisayuki Shuto et al. PLoS One
- Rational use of the fluoroquinolones
- (2019) G A Richards et al. SAMJ SOUTH AFRICAN MEDICAL JOURNAL
- Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease
- (2018) Roland Diel et al. CHEST
- Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
- (2018) Jakko van Ingen et al. EUROPEAN RESPIRATORY JOURNAL
- Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
- (2017) Won-Jung Koh et al. EUROPEAN RESPIRATORY JOURNAL
- Minimum inhibitory concentration distributions for Mycobacterium avium complex—towards evidence-based susceptibility breakpoints
- (2017) Thomas Schön et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- (2017) Charles S Haworth et al. THORAX
- Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases
- (2016) Jakko van Ingen et al. EUROPEAN RESPIRATORY JOURNAL
- Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease
- (2015) Tsukasa Kadota et al. BMC INFECTIOUS DISEASES
- Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
- (2015) D. Rebecca Prevots et al. CLINICS IN CHEST MEDICINE
- Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
- (2015) David W. Denning et al. EUROPEAN RESPIRATORY JOURNAL
- Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
- (2014) Richard J. Wallace et al. CHEST
- The clinical spectrum of pulmonary aspergillosis
- (2014) C. Kosmidis et al. THORAX
- Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen
- (2013) Won-Jung Koh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis
- (2013) H.-B. Xu et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clinical Significance of the Differentiation Between Mycobacterium avium and Mycobacterium intracellulare in M avium Complex Lung Disease
- (2012) Won-Jung Koh et al. CHEST
- Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease
- (2012) S. Kitada et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Prognostic Factors of 634 HIV-Negative Patients withMycobacterium aviumComplex Lung Disease
- (2011) Makoto Hayashi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium
- (2011) Chiaki Sano et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started